Canada/Ottawa:
Health Canada, a Canadian health regulatory authority, warns patients, physicians and other healthcare professionals that Tecentriq (Atezolizumab) may increase the risk of Myocarditis, a serious health and safety hazards. HCSC: http://ht.ly/fJC630iwzoN
Direct link: http://healthycanadians.gc.ca/recall-alert-rappel-avis/hc-sc/2018/65990a-eng.php
Additional information:
Health Canada/Santé Canada (“HCSC”) reports the following drug products are subject to this recall:
Filed under: Drugs, Health Canada/Santé Canada, Home & Residential, Medical / Veterinary, Tecentriq (Atezolizumab) | Tagged: HCSC ID number: RA-65990, Health Canada, Hoffmann-La Roche, injury hazard, Myocarditis, Recalls Direct RIN: 9806-2018, Tecentriq (Atezolizumab) | Leave a comment »